文献速递胸部肿瘤

2023年欧洲癌症死亡率预测:聚焦肺癌

European cancer mortality predictions for the year 2023 with focus on lung cancer.
PubMed 文献 · Ann Oncol · 2023-03-06

该研究基于世界卫生组织与欧盟统计局1970-2018年癌症死亡登记及人口数据,预测欧盟27国、其五个人口最多国家及英国2023年全癌种与十大常见癌种的死亡数与年龄标准化率,并聚焦肺癌。预测欧盟27国2023年癌症死亡1261990例,男性年龄标准化率123.8/10万(较2018年下降6.5%),女性79.3/10万(下降3.7%)。

要点

  • 欧盟27国2023年预测癌症死亡1261990例,男性年龄标准化率123.8/10万、女性79.3/10万。
  • 1989-2023年欧盟27国较1988年峰值避免约5862600例癌症死亡。
  • 女性肺癌死亡率在年轻组(下降35.8%)和中年组(下降7%)下降,但老年组(65岁以上)仍上升10%。

核心结论

  • 欧盟27国2023年预测癌症死亡1261990例,男性年龄标准化率123.8/10万(较2018年下降6.5%),女性79.3/10万(下降3.7%)。
  • 1989-2023年欧盟27国较1988年峰值避免约5862600例癌症死亡。
  • 烟草控制的进步反映在肺癌死亡率的有利趋势中,应进一步推进。
  • 作者认为,加大超重与肥胖、饮酒、感染及相关肿瘤控制力度,并改进筛查、早期诊断和治疗,可能使欧盟到2035年癌症死亡率进一步下降35%。

研究设计与样本

  • 基于世界卫生组织与欧盟统计局数据库1970-2018年癌症死亡登记及人口数据,预测欧盟27国、其五个人口最多国家及英国2023年死亡数与年龄标准化率。
  • 预测对象为全癌种及十大常见癌种,并分析观察期内趋势变化。
  • 估算1989-2023年全癌种及肺癌避免死亡数。

主要发现

  • 欧盟27国2023年预测癌症死亡1261990例。
  • 胰腺癌在欧盟男性中稳定(8.2/10万),在欧盟女性中上升3.4%(5.9/10万)。
  • 女性肺癌趋于平稳(13.6/10万)。
  • 结直肠癌、乳腺癌、前列腺癌、白血病、男女胃癌及男性膀胱癌死亡率预测持续下降。
  • 男性肺癌各年龄组死亡率均下降;女性肺癌年轻组下降35.8%(年龄标准化率0.8/10万)、中年组下降7%(31.2/10万),但老年组(65岁以上)上升10%。

关键数值与推荐

  • 欧盟27国2023年男性全癌种年龄标准化率123.8/10万,较2018年下降6.5%。
  • 欧盟27国2023年女性全癌种年龄标准化率79.3/10万,较2018年下降3.7%。
  • 1989-2023年欧盟27国较1988年峰值避免约5862600例癌症死亡。
  • 女性肺癌年轻组年龄标准化率0.8/10万(下降35.8%),中年组31.2/10万(下降7%),老年组(65岁以上)上升10%。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: We predicted cancer mortality figures for 2023 for the European Union (EU-27), its five most populous countries, and the UK. We also focused on mortality from lung cancer. MATERIALS AND METHODS: Using cancer death certification and population data from the World Health Organization and Eurostat databases for 1970-2018, we predicted numbers of deaths and age-standardized rates (ASRs) for 2023 for all cancers combined and the 10 most common cancer sites. We investigated the changes in trends over the observed period. The number of avoided deaths over the period 1989-2023 were estimated for all cancers as well as lung cancer. RESULTS: We predicted 1 261 990 cancer deaths for 2023 in the EU-27, corresponding to ASRs of 123.8/100 000 men (-6.5% versus 2018) and 79.3 for women (-3.7%). Over 1989-2023, ∼5 862 600 cancer deaths were avoided in the EU-27 compared with peak rates in 1988. Most cancers displayed favorable predicted rates, with the exceptions of pancreatic cancer, which was stable in EU men (8.2/100 000) and rose by 3.4% in EU women (5.9/100 000), and female lung cancer, which, however, tends to level off (13.6/100 000). Steady declines are predicted for colorectal, breast, prostate, leukemia, stomach in both sexes, and male bladder cancers. The focus on lung cancer showed falls in mortality for all age groups in men. Female lung cancer mortality declined in the young (-35.8%, ASR: 0.8/100 000) and middle-aged (-7%, ASR: 31.2/100 000) but still increased by 10% in the elderly (age 65+ years). CONCLUSIONS: The advancements in tobacco control are reflected in favorable lung cancer trends, and should be pushed further. Greater efforts on the control of overweight and obesity, alcohol consumption, infection and related neoplasms, together with improvements in screening, early diagnosis, and treatments may achieve a further 35% reduction in cancer mortality in the EU by 2035.

来源:Ann Oncol,查看原文。版权归原作者所有。

引用

  1. Malvezzi M, Santucci C, Boffetta P, et al. European cancer mortality predictions for the year 2023 with focus on lung cancer. Ann Oncol. 2023. PMID: 36882139. doi:10.1016/j.annonc.2023.01.010

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。